Scholars Central

Took place13th editionPharmaceutical Sciences

13th Global Pharmacovigilance & Clinical Trials Summit

When
28–29 Mar 2019

Programme

15 sessions

15 sessions

Keynote Forum · Thursday 28 Mar 2019

  1. Pragmatic Clinical Trials - Hope or HypeJacob Joseph
  2. Deep Dive in aspects of Pharmacovigilance for Biologics, Bio-Similar and VaccinesUjwala Vilas Salvi

Clinical Database Management · Thursday 28 Mar 2019Osaka,Japan

  1. Data Integrity: What the Government Wants, and How Technology May HelpChi Chen, Rajiv Joshi · Osaka,Japan
  2. A study to compare efficacy of Metformin-Glimepiride versus Metformin-Tenelig liptinin Type II Diabetic PatientsMd.Gayoor khan · Osaka,Japan
  3. Patient records studies : for Pharma companies and for scienceCarole Gabay · Osaka,Japan

Good Pharmacovigilance Practise · Thursday 28 Mar 2019Osaka,Japan

  1. Guideline on Good Pharmacogivilance Practices (GVP) Module V – Risk Management Systems (Revision 2) – Updates and FeedbackFawad Piracha · Osaka,Japan

Drug Safety · Thursday 28 Mar 2019

  1. Pharma-Safe” Medication Safety Best Practice Standards in community pharmacyAbeer Muhanna
  2. Challenges in Breast Cancer Treatment and Long-Term Drug SafetyAshok Srivastava

Keynote Forum · Friday 29 Mar 2019

  1. Internal Safety Advisory Groups (ISAG): A Win-Win for Effective Decision-Making in Biopharmaceutical CompaniesMeenal Patwardhan
  2. Under-representation of vulnerable population in clinical trials impacts negatively on drug development and safety evaluation of new medicineAssem S. el Baghdady

Adverse Drug Effects · Friday 29 Mar 2019

  1. Integrating Regulatory Drug Label Information to Facilitate Evaluation of Adverse Events in PharmacovigilanceZhou (Tom) Hui
  2. Some aspects of Fake and counterfeiting of drugs: Sudan caseAbdeen Omer

Drug Safety · Friday 29 Mar 2019

  1. Medication Safety in Health care FacilityFathima Atima Yousef Ali Ghethan
  2. Monitoring Pharmacovigilance quality system is important indicator for pharmaceuticals’ compliance.Essam Ghanem
  3. Clinical Trial Safety Monitoring: Requirement of eSAE systemRipal Gharia

Recap

15 abstracts presented at this edition, linked from the programme.

Talks and sessions
15
Days
2
Tracks
5
Abstracts held here
15

Thursday 28 Mar 2019 – Friday 29 Mar 2019

Tracks, and how many items each carried

  • Drug Safety5
  • Keynote Forum4
  • Clinical Database Management3
  • Adverse Drug Effects2
  • Good Pharmacovigilance Practise1

Keynotes and plenaries, as the programme printed them

  • Pragmatic Clinical Trials - Hope or HypeJacob Joseph
  • Deep Dive in aspects of Pharmacovigilance for Biologics, Bio-Similar and VaccinesUjwala Vilas Salvi
  • Internal Safety Advisory Groups (ISAG): A Win-Win for Effective Decision-Making in Biopharmaceutical CompaniesMeenal Patwardhan
  • Under-representation of vulnerable population in clinical trials impacts negatively on drug development and safety evaluation of new medicineAssem S. el Baghdady

Names as printed in the programme. Scholars Central adds no affiliation to them.

No session summary has been checked for this event yet.

What this programme does not say
  • The programme does not say how many people attended, and Scholars Central keeps no record of who attended.
  • Nothing here comes from a recording, a transcript or the discussion in the room: there are none.
  • The programme as published prints no times.

A programme is published for about one past event in five, so a digest is not available for every event.

Website and contact

Sponsor, exhibit or ask

This edition has ended. You can still send the organisers a question.

Something wrong on this page?

Tell the Scholars Central team about a wrong date or place, a broken link, or anything else.

Journals and research

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels